User shares 4-month progress using finasteride, minoxidil, and microneedling for hair loss. Others discuss body hair, hair transplant possibilities, and user's treatment response.
The user is experiencing hair regrowth using 1mg oral finasteride daily, Minoxidil foam twice a day, and microneedling weekly with a 1.5mm needle. They are seeking feedback and suggestions to optimize their hair regrowth.
The user experienced significant hair regrowth using topical Minoxidil and Finasteride, along with Saw Palmetto and volumizing shampoo. They are considering a hair transplant in the future if needed.
The conversation discusses a user's experiment of "burning the scalp" to treat hair loss, with mixed opinions on its effectiveness. Some suggest returning to proven treatments like finasteride and minoxidil, while others note slight improvements in hair density.
The conversation discusses unconventional methods for hair regrowth, including scalp trauma like burning or microneedling, and compares them to treatments like Minoxidil and Finasteride. It highlights skepticism about these methods and the body's unpredictable healing responses.
After a hair transplant, using finasteride and minoxidil is common to support graft survival and prevent future hair loss. Dermastamping can enhance effectiveness, while saw palmetto may offer weak DHT blocking benefits.
The conversation discusses using minoxidil and finasteride for hair loss, with concerns about absorption and considering adding tretinoin for better results. Microneedling is suggested as a method to improve absorption, with varying depths and frequencies recommended.
The post discusses a user's struggle with hair loss and the ineffectiveness of finasteride. Suggestions from the conversation include trying oral minoxidil and considering a 3200 graft hair transplant.
A user's 6-month progress after using oral finasteride, topical minoxidil, and weekly dermaroller treatments for hair loss. Replies praised the user for their results so far.
The conversation discusses positive initial trial results for GT20029, a topical compound for hair loss that degrades androgen receptors, potentially requiring only weekly application. Participants express hope for this treatment to be more effective and convenient than current options like Minoxidil, Finasteride, and RU58841.